본문 바로가기
bar_progress

Text Size

Close

Samsung Biologics, 12 Consecutive Years at BioUSA... "Leap to Global Leading Company"

Samsung Biologics announced on the 27th that it will participate in the world's largest bio and pharmaceutical exhibition, the '2024 BIO International Convention (BIO USA)'.


Samsung Biologics, 12 Consecutive Years at BioUSA... "Leap to Global Leading Company" A bird's-eye view of the Samsung Biologics booth to be installed at the 2024 BIO International Convention (BIO USA) to be held next month in San Diego, California, USA.
[Photo by Samsung Biologics]

BIO USA is an event held every summer in major bio clusters across the United States, organized by the Biotechnology Innovation Organization (BIO). It is regarded as a networking platform where stakeholders from the global biopharmaceutical industry gather to discuss partnerships. This year, it will be held for four days from June 3 to 6 (local time) in San Diego, California, under the theme "Time for Science to Shine." More than 1,500 companies and over 20,000 attendees are expected to visit the venue.


Samsung Biologics, participating with a solo booth for 12 consecutive years since its founding, plans to set up a 139㎡ booth at the center of the exhibition hall and conduct business networking through various contents and events.


The booth walls will feature a content wall showcasing the company's innovations and achievements at a glance, and LED panels providing various videos will highlight Samsung Biologics' contract development and manufacturing organization (CDMO) competitiveness. Emphasis will be placed on the world's largest biopharmaceutical production capacity (784,000 liters), including the 5th plant scheduled for completion next year, customer-tailored contract development (CDO) platform services, and the expansion of the antibody-drug conjugate (ADC) portfolio. In particular, the company aims to complete the 2nd Bio Campus (plants 5 to 8) by 2032, achieving a total CDMO production scale of 1,324,000 liters, creating an ultra-competitive gap.


Additionally, Samsung Biologics will unveil its new CDO slogan, "Agile, Flexible, Focused on You," and actively pursue global customer orders. This slogan reflects the CDO service mindset and global competitiveness to provide fast and flexible customized solutions for customer success, as well as the ambition to become a leading global CDMO company.


Furthermore, instead of traditional printed brochures, the company plans to promote its commitment to ESG (Environmental, Social, and Governance) by providing digital brochures via QR codes, eco-friendly bags, and souvenirs.


Samsung Biologics, 12 Consecutive Years at BioUSA... "Leap to Global Leading Company" Promotional banner of Samsung Biologics hanging on the main road near the venue of the BIO International Convention (BIO USA) held in San Diego, USA, in 2022.
[Photo by Samsung Biologics]

Meanwhile, during the exhibition, Samsung Biologics will also engage in sponsorship activities to enhance brand awareness. More than 140 banners will be installed along Harbor Drive, the main road along the coast from San Diego Airport to the exhibition center, as well as on street lamps near the venue. Additionally, four digital banner video advertisements will be displayed in the main lobby of the exhibition hall to increase recognition of Samsung Biologics' vision and service competitiveness.


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Special Coverage


Join us on social!

Top